Publications

A range of publications and thought leadership is available to UK pharmaceuticals companies:

Pharma 2020: The vision - which path will you take?
This podcast and global report looks at the challenges facing the pharmaceuticals sector in the lead up to 2020.

IFRS - impact on financial reporting for the life sciences sector

BioForum - latest issue
This edition reports market performance data for another strong quarter and a milestone of $30 billion total market value for the Biotechnology sector. The market has shown consistent strength in the capital raising through initial public offerings and secondary raisings in both the biotech/pharma and medical device subsectors.

Unlocking the power of pharmacovigilance
This report is a focused analysis of the current state of drug safety monitoring (known as pharmacovigilance) and a guide to field-tested operational strategies that can be employed to improve current pharmacovigilance practices.

Restoring trust in the pharmaceutical industry by translating expectations into actions
This report provides an in-depth analysis of one of the most pressing issues facing the global pharmaceutical industry today – its reputation and how it deals with perceptions about its business and operational models.

International Financial Reporting Standards (IFRS): Issues and solutions for the pharma industry
A series of in-depth publications designed to create dialogue and debate around the issues of implementing IFRS and encourage consistent global best practices in financial reporting under these new standards.

A better shape for the future: Building value through integration and partnerships
This European pharmaceutical market survey from PricewaterhouseCoopers & Siemens demonstrates that there is a demand for truly integrated multi-disciplinary services.

Pharmaceutical Insights: Analysis and Opinions on Merger & Acquisition Activity
An annual overview of M&A activity in the global pharmaceuticals industry, together with analysis of the principal trends and driving forces in the arena, now and in the future.

Prescription for Growth – series of papers
A series of paper examining the opportunities and risks attached to investing in developing markets. The series includes focuses on China, India and Latin America.